Sequential Dual Nanoparticle Approach for Extracellular Matrix Remodeling and Targeted Chemotherapy through Liposome–Exosome Hybridization in Pancreatic Cancer
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c14250 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Sejin Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon34141, Republic of Korea. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Extracellular Matrix, Liposomes, Doxorubicin. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Pancreatic cancer remains one of the most aggressive and treatment-resistant malignancies, with a poor prognosis and limited response to conventional therapies. Although liposomal doxorubicin (DOX) formulations reduce systemic toxicity, their clinical use is constrained by insufficient tumor targeting and poor intratumoral penetration. Here, we report a sequential dual-nanoparticle approach that integrates extracellular matrix (ECM) remodeling with tumor-targeted chemotherapy to overcome these barriers. Hyaluronidase-loaded liposomes (LH) were first employed to degrade hyaluronic acid–rich ECM, followed by the administration of DOX-loaded liposome–exosome hybrid nanoparticles (HLD) engineered using pancreatic cancer cell–derived exosomes to confer intrinsic tumor-homing capability. The DOX-loaded hybrid nanoparticles demonstrated enhanced cellular uptake, potent cytotoxicity, and strong immunogenic cell death (ICD) responses in pancreatic cancer cells. ECM degradation by LH significantly improved intratumoral accumulation and penetration of subsequently administered HLD in vivo. In a pancreatic cancer xenograft model, sequential LH and HLD treatment resulted in superior tumor growth suppression compared with monotherapies, without inducing systemic toxicity. Collectively, this work demonstrates a modular, sequential nanotherapeutic platform that synergistically combines ECM remodeling and exosome-mediated targeting, offering a promising strategy to improve drug delivery and therapeutic efficacy in stromal-dense solid tumors, such as pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon34141, Republic of Korea.
- Department of Chemical and Biological Engineering, Korea National University of Transportation, Chungju27469, Republic of Korea.
- 4D Convergence Technology Institute (National Key Technology Institute in University), Korea National University of Transportation, Jeungpyeong27909, Republic of Korea.
ORCID-Profile: Yeu-Chun Kim
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
Zitieren
APA
Kim, S., Park, H., Kim, S., Lee, S., Liu, H., Nam, H., Choi, Y., Lee, Y. K., & Kim, Y. C. (2026). Sequential Dual Nanoparticle Approach for Extracellular Matrix Remodeling and Targeted Chemotherapy through Liposome–Exosome Hybridization in Pancreatic Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c14250
Vancouver
Kim S, Park H, Kim S, Lee S, Liu H, Nam H, et al. Sequential Dual Nanoparticle Approach for Extracellular Matrix Remodeling and Targeted Chemotherapy through Liposome–Exosome Hybridization in Pancreatic Cancer. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c14250
BibTeX
@article{Kim2026,
author = {Kim, Sejin and Park, Heewon and Kim, Seungcheol and Lee, Susam and Liu, Haoyan and Nam, Hoyeon and Choi, Yuri and Lee, Yong-Kyu and Kim, Yeu-Chun},
title = {Sequential Dual Nanoparticle Approach for Extracellular Matrix Remodeling and Targeted Chemotherapy through Liposome–Exosome Hybridization in Pancreatic Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c14250}
}
EUVIMED